More Company News

Nexstim

Positive feedback from leading Austrian clinic on its first NBT system
18 Jun 2019Read More

Nexstim

Amendment of stock option programmes
10 Jun 2019Read More

Nexstim

NBS system sold to Jewish General Hospital in Canada
28 May 2019Read More

Nexstim

Amendment of terms of warrants
23 May 2019Read More

Nexstim

First NBT system sold in Germany for depression therapy and research
22 May 2019Read More

Nexstim

Final outcome of the subscription rights issue
21 May 2019Read More

Nexstim

The trading of offer warrants begins
20 May 2019Read More

Nexstim

Nexstim enters depression therapy market in Sweden
10 May 2019Read More

Nexstim

Professor Paul Fitzgerald joins Scientific Advisory Board
24 Apr 2019Read More

Nexstim

Professor Turo Nurmikko joins Scientific Advisory Board
16 Apr 2019Read More

1 2 3 4 5 6 7 8
Return to Nexstim
© 2019-20 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).